Citation Impact
Citing Papers
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
2016 Standout
Understanding biofilm resistance to antibacterial agents
2003 Standout
The epidemiology of urinary tract infection
2010 Standout
Three-day vs longer duration of antibiotic treatment for cystitis in women: Systematic review and meta-analysis
2005
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
2012 Standout
Calcium signalling: dynamics, homeostasis and remodelling
2003 Standout
Depression Is a Risk Factor for Noncompliance With Medical Treatment
2000 Standout
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
2014 Standout
State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men
1998 Standout
Ciprofloxacin: In Vitro Activity, Mechanism of Action, and Resistance
1988
Treatment of Community-Acquired Acute Uncomplicated Urinary Tract Infection with Sparfloxacin versus Ofloxacin
1998
Antifungal activity of the components of Melaleuca alternifolia (tea tree) oil
2003 Standout
DIAGNOSIS AND TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION
1997 Standout
The Clinical Relevance of Plasma Protein Binding Changes
2012
University of California/Davis Interdepartmental Conference on Gram-Negative Septicemia
1991 StandoutNobel
EAU Guidelines for the Management of Urinary and Male Genital Tract Infections<sup>1</sup>
2001
Use of quinolones in treatment of prostatitis and lower urinary tract infections
1991
Eugenol (an essential oil of clove) acts as an antibacterial agent against Salmonella typhi by disrupting the cellular membrane
2010 Standout
Penetration of fusidic acid into human brain tissue and cerebrospinal fluid
1993
Patient Adherence and Medical Treatment Outcomes
2002 Standout
In vitro bactericidal activity of amoxicillin, gentamicin, rifampicin, ciprofloxacin and trimethoprim-sulfamethoxazole alone or in combination againstListeria monocytogenes
1990
Serenoa repens associated with Urtica dioica (ProstaMEV®) and curcumin and quercitin (FlogMEV®) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study
2009
Fluoroquinolones: Action and Resistance
2003
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
Antimicrobial agents from plants: antibacterial activity of plant volatile oils
2000 Standout
Uncomplicated Urinary Tract Infection
2012 Standout
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Levofloxacin
2003
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review
2009 Standout
Cationic antiseptics: diversity of action under a common epithet
2005 Standout
Penetration of fusidic acid and rifampicin into cerebrospinal fluid in low-grade inflammatory meningitis caused by Staphylococcus epidermidis
2004
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Antibiotic Pharmacokinetics in Cystic Fibrosis
1987
The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients
2010
Antifouling Coatings: Recent Developments in the Design of Surfaces That Prevent Fouling by Proteins, Bacteria, and Marine Organisms
2010 Standout
Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women
1999
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Aeromonas sobria prostatitis and septic shock in a healthy man with chronic alcoholic consumption.
2007
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Tobramycin
1976
Leptospirosis
2001 Standout
Development of resistance during antibiotic therapy
1987
The Use and Misuse of New Antibiotics
1995
Once Daily, Extended Release Ciprofloxacin for Complicated Urinary Tract Infections and Acute Uncomplicated Pyelonephritis
2004
Physicochemical properties of the fluoroquinolone antimicrobials. III. Complexation of lomefloxacin with various metal ions and the effect of metal ion complexation on aqueous solubility
1992
Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women
2002
Microbiological efficacy and pharmacokinetics of prophylactic antibiotics in liver transplant patients
1992
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features
1996 Standout
International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
2011 Standout
Characterization of Acinetobacter haemolyticus aac(6')-Ig gene encoding an aminoglycoside 6'-N-acetyltransferase which modifies amikacin
1993
Minocycline: far beyond an antibiotic
2013 Standout
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
In vitro susceptibilities of five Leptospira strains to 16 antimicrobial agents
1983
Sorption of Veterinary Pharmaceuticals in Soils: A Review
2001 Standout
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
The GenusAeromonas: Taxonomy, Pathogenicity, and Infection
2010 Standout
The Crisis in Antibiotic Resistance
1992 StandoutScience
Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance
1987
IDENTIFICATION OF SITE OF URINARY-TRACT INFECTIONS BY ANTIBODY-COATED BACTERIA ASSAY
1979
Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.
1994
Interactions between Biocide Cationic Agents and Bacterial Biofilms
2002
Potentiation of Ca 2+ Release by cADP-Ribose in the Heart Is Mediated by Enhanced SR Ca 2+ Uptake Into the Sarcoplasmic Reticulum
2001
Antibiotic Resistance in Listeria spp
1999 StandoutNobel
Antibiotic susceptibility of deoxyribonuclease-positive enterococci isolated from milk and milk products and their epidemiological significance
1986
A comparison of cefotetan and cephazolin for prophylaxis against wound infection after elective cholecystectomy
1985
Clinical trial of fusidic acid for lepromatous leprosy
1994
Investigations of the Antibacterial Properties of Ciprofloxacin@SiO2
2006
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
The Continuing Challenges of Leprosy
2006 Standout
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Levofloxacin and Sparfloxacin: New Quinolone Antibiotics
1998
Works of J Guibert being referenced
Ofloxacine (RU 43280): évaluation clinique dans les infections urinaires et prostatiques.
1986
Mechanism of Action of Sarcoplasmic Reticulum Calcium‐Uptake Activators
1997
Pharmacokinetics of sodium fusidate after single and repeated infusions and oral administration of a new formulation
1990
The Role of Antibiotics in the Treatment of Chronic Prostatitis:A Consensus Statement
1998
Comparative efficacy of sparfloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection
1996
[Antibody coated bacteria in urinary sediment (author's transl)].
1976
Ciprofloxacin in the Treatment of Urinary Tract Infection due to Enterobacteria
1986
Pharmacokinetics of single intravenous and intramuscular doses of cefotetan in normal human volunteers
1983
Evaluation clinique et bactériologique de l’amoxicilline en dehors des infections à entérobactéries
1973
[Treatment of uncomplicated recurrent cystitis in women: lomefloxacin versus norfloxacin].
1997
Pharmacokinetics of cefotiam in humans
1985
Ciprofloxacin in the treatment of urinary tract infection due to enterobacteria
1986
[Treatment of non-complicated acute cystitis in women: lomefloxacin versus pefloxacin].
1996
Pharmacokinetics of cefotaxime in normal human volunteers
1980
Pharmacokinetics and bioavailability of intramuscular preparations of ticarcillin
1982
The new quinolones and their combinations with other agents for therapy of severe infections
1986
Septicémie à moraxella et streptocoque d
1974
[Ofloxacin (RU 43280): clinical evaluation in urinary and prostatic infections].
1986